Australian Clinical Labs Ltd (ASX:ACL)
A$ 3.47 0 (0%) Market Cap: 700.36 Mil Enterprise Value: 983.36 Mil PE Ratio: 28.92 PB Ratio: 3.94 GF Score: 54/100

Australian Clinical Labs Ltd To Merge with Healius Ltd Call Transcript

Mar 19, 2023 / 11:30PM GMT
Michael Alscher
Australian Clinical Labs Limited - Non-executive Chair

Good morning, everyone, and welcome to the presentation on Australian Clinical Labs' takeover offer for Healius Limited. On behalf of ACL, I'd like to start by acknowledging the traditional custodians of the land from which we meet today, which, from [Melinda and I, are] the lands of the Gadigal people of the Eora Nation.

We acknowledge the traditional custodians of country throughout Australia and the places from which our participants join us on this webinar and their connections to land, sea, and community. We pay our respects to their elders past and present and extend that respect to Aboriginal and Torres Strait Islander peoples here today.

My name is Michael Alscher, and I'm the Chair of Australian Clinical Labs. Before I introduce Melinda McGrath, the CEO, I'd like to make a few comments of my own.

On behalf of the Board of ACL, we're extremely excited about the opportunity we are presenting to the respective shareholders of both companies to merge Healius with Australian Clinical Labs. The value

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot